Lexaria Bioscience (LEXXW) Short Interest Ratio & Short Volume $0.29 -0.01 (-3.91%) As of 09:38 AM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock Lexaria Bioscience Short Interest DataLexaria Bioscience (LEXXW) has a short interest of 5,800 shares. This marks a -3.33% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 11,374 shares to cover all short positions.Current Short Interest5,800 sharesPrevious Short Interest6,000 sharesChange Vs. Previous Month-3.33%Dollar Volume Sold Short$2,146.58Short Interest Ratio0.6 Days to CoverLast Record DateApril 15, 2025Today's Trading Volume208 sharesAverage Trading Volume11,374 sharesToday's Volume Vs. Average2% Short Selling Lexaria Bioscience? Sign up to receive the latest short interest report for Lexaria Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLEXXW Short Interest Over TimeLEXXW Days to Cover Over TimeLEXXW Percentage of Float Shorted Over Time Lexaria Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20255,800 shares $2,146.58 -3.3%N/A0.6 $0.37 3/31/20256,000 shares $2,261.40 +150.0%N/A0.6 $0.38 3/15/20252,400 shares $623.28 +20.0%N/A0.2 $0.26 2/28/20252,000 shares $498.00 -41.2%N/A0.2 $0.25 2/15/20253,400 shares $1,156.00 +3.0%N/A0.3 $0.34 1/31/20253,300 shares $1,257.30 +73.7%N/A0.5 $0.38 1/15/20251,900 shares $1,329.81 -70.3%N/A0.4 $0.70 12/31/20246,400 shares $4,890.24 -21.0%N/A1.2 $0.76 12/15/20248,100 shares $6,318.00 +161.3%N/A1.3 $0.78 11/30/20243,100 shares $2,480.00 -8.8%N/A0.3 $0.80 Get the Latest News and Ratings for LEXXW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter. 11/15/20243,400 shares $2,074.00 +30.8%N/A0.3 $0.61 10/31/20242,600 shares $1,820.00 -49.0%N/A0.2 $0.70 10/15/20245,100 shares $3,886.20 +41.7%N/A0.4 $0.76 9/30/20243,600 shares $3,308.40 -68.7%N/A0.3 $0.92 9/15/202411,500 shares $11,500.00 +202.6%N/A0.9 $1.00 8/31/20243,800 shares $5,320.00 +46.2%N/A0.5 $1.40 8/15/20242,600 shares $3,900.00 +766.7%N/A0.4 $1.50 7/31/2024300 shares $336.00 -62.5%N/A0 $1.12 7/15/2024800 shares $800.00 +700.0%N/A0.1 $1.00 6/30/2024100 shares $80.63 No ChangeN/A0 $0.81 6/15/2024100 shares $138.00 -98.2%N/A0 $1.38 5/31/20245,400 shares $8,046.00 +92.9%N/A0.3 $1.49 5/15/20242,800 shares $3,780.00 -36.4%N/A0.1 $1.35 4/30/20244,400 shares $4,319.04 -74.4%N/A0.2 $0.98 4/15/202417,200 shares $12,038.28 -23.6%N/A1.4 $0.70 3/31/202422,500 shares $33,750.00 +4.2%N/A1.9 $1.50 3/15/202421,600 shares $22,248.00 +14.3%N/A1.8 $1.03 2/29/202418,900 shares $15,120.00 -33.9%N/A1.8 $0.80 2/15/202428,600 shares $24,024.00 +9.2%N/A3.9 $0.84 1/31/202426,200 shares $12,080.82 No ChangeN/A3.4 $0.46 12/30/2022900 shares $359.91 No ChangeN/A0.2 $0.40 12/15/2022900 shares $414.00 +12.5%N/A0.2 $0.46 11/30/2022800 shares $456.00 +14.3%N/A0.1 $0.57 11/15/2022700 shares $406.00 +16.7%N/A0.1 $0.58 10/31/2022600 shares $360.00 -93.8%N/A0.1 $0.60 10/15/20229,600 shares $4,599.36 +9.1%N/A1.8 $0.48 9/30/20228,800 shares $5,192.00 +877.8%N/A2.1 $0.59 9/15/2022900 shares $729.00 +28.6%N/A0.2 $0.81 8/31/2022700 shares $518.07 +16.7%N/A0.3 $0.74 8/15/2022600 shares $498.06 +50.0%N/A0.2 $0.83How to invest in Elon Musk’s Optimus before its launch (Ad)Elon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that Elon Musk himself believes "will be the biggest product ever of any kind". One well-connected Silicon Valley insider has uncovered a way for anybody to claim a stake in Optimus with as little as $100. All you'll need is a regular brokerage account.Get all the information here. 7/31/2022400 shares $260.28 +100.0%N/A0.2 $0.65 7/15/2022200 shares $180.02 No ChangeN/A0.1 $0.90 LEXXW Short Interest - Frequently Asked Questions What is Lexaria Bioscience's current short interest? Short interest is the volume of Lexaria Bioscience shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 5,800 shares of LEXXW short. Learn More on Lexaria Bioscience's current short interest. What is a good short interest ratio for Lexaria Bioscience? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LEXXW shares currently have a short interest ratio of 1.0. Learn More on Lexaria Bioscience's short interest ratio. Is Lexaria Bioscience's short interest increasing or decreasing? Lexaria Bioscience saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 5,800 shares, a drop of 3.3% from the previous total of 6,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Lexaria Bioscience stock? Short selling LEXXW is an investing strategy that aims to generate trading profit from Lexaria Bioscience as its price is falling. LEXXW shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lexaria Bioscience? A short squeeze for Lexaria Bioscience occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LEXXW, which in turn drives the price of the stock up even further. How often is Lexaria Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LEXXW, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies ALVOW Short Squeeze BCTXW Short Squeeze CLNNW Short Squeeze ENGNW Short Squeeze FBIOP Short Squeeze IMTXW Short Squeeze JSPRW Short Squeeze LIXTW Short Squeeze NLSPW Short Squeeze NRXPW Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LEXXW) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexaria Bioscience Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexaria Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.